Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhancement of MSC immunomodulatory properties by treprostinil

Enhancement of MSC immunomodulatory properties by treprostinil

US Patent 11571444 · Granted Feb 7, 2023

Estimated economic value: $51,748,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Automated bioreactor system, system for automatically implementing protocol for 2025
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2025
Bioactive renal cells2024
Automated bioreactor system, system for automatically implementing protocol for 2024
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2023
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2023
Treatment of pulmonary arterial hypertension with mesenchymal stem cells2023
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2021
Bioactive renal cells2021
Extracellular vesicles with enhanced potency2021
Extracellular vesicles with enhanced potency2021